PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial offers hope for patients with aggressive blood cancers
Disease control Recruiting nowThis early-phase study is testing the safety of a new personalized cell therapy called CART123 for adults with advanced blood cancers that have returned or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target cancer,…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with leukemia that Won't quit: pioneering cell therapy trial begins
Disease control Recruiting nowThis early-stage trial is testing the safety and feasibility of two new types of CAR-T cell therapy for children and young adults with leukemia that has come back or hasn't responded to standard treatments. One therapy targets a common form of B-cell leukemia, while the other is …
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Gentler combo therapy tested for tough blood cancer
Disease control Recruiting nowThis study is testing a new treatment plan for adults newly diagnosed with a fast-growing blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The goal is to see if using lower-dose chemotherapy together with newer immune-targeting drugs can effectively control the di…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for kids with tough cancers: early trial tests promising drug
Disease control Recruiting nowThis early-stage study is testing a drug called TURALIO in children and young adults (ages 3-35) whose cancers have returned or not responded to standard treatments. The main goals are to find the highest safe dose of the drug and understand its side effects. Participants will ta…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
One-Time infusion aims to fight tough blood cancers from within
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new, one-time gene therapy called INT2104 for adults with B-cell blood cancers that have returned or not responded to prior treatments. The therapy is designed to instruct the body's own immune cells to find and fight cancer …
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Feb 23, 2026 14:57 UTC